GLOBAL TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Nov 2018 117

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in humans. It is mainly characterized into two main types i.e. Hereditary ATTR (hATTR) and Wild-Type (wt) ATTR. While Hereditary ATTR is caused by point mutations within TTR allele, wild-type ATTR is caused by the misfolding of Wild-Type TTR. Major prevalence of Hereditary ATTR is observed in the 7MM, and this type has been further sub-classified into Familial Amyloidosis Polyneuropathy (FAP) and Familial Amyloidosis Cardiomyopathy (FAC).

Scope of the Report:

This report studies the Transthyretin Amyloidosis (ATTR) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Transthyretin Amyloidosis (ATTR) market by product type and applications/end industries.

United States accounts for highest ATTR Amyloidosis Cases, followed by EU5 (Italy, France, Spain, Germany, UK) and Japan.

The global Transthyretin Amyloidosis (ATTR) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Transthyretin Amyloidosis (ATTR).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
- Pfizer
- Alnylam Pharmaceuticals
- Ionis Pharmaceuticals
- Corino Therapeutics
- Proclara Bioscience
- Arcturus Therapeutics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Hereditary ATTR (HATTR)
- Wild-Type (WT) ATTR

Market Segment by Applications, can be divided into
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers

Table of Contents

Related reports :

(Nov 18)

Fetal and neonatal equipment are mostly used to monitor, evaluate, and treat diseases in the prenatal and postnatal stages of infants....

(Nov 18)

In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infecti...

(Nov 18)

An electrocardiograph is a machine that is used to perform electrocardiography, and produces the electrocardiogram. Scope of ...

(Nov 18)

Drug discovery is the process by which new candidate medications are discovered. Scope of the Report: This rep...

(Nov 18)

Digital radiography is a form of X-ray imaging, where digital X-ray sensors are used instead of traditional photographic film. ...

(Nov 18)

Dental sealants are a dental treatment intended to prevent tooth decay. Scope of the Report: This report focus...

GLOBAL TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy